	R 2012 Mar 31	C 2013 Mar 31	C 2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	318	371	571	614	716	779	789	733	908	901	1,146	1,050	1,152	1,286	1,539
Cost of Operating Revenue	208	241	360	371	420	436	431	342	371	375	529	583	582	592	580
Gross Profit	110	130	211	243	296	343	358	391	537	526	616	468	570	695	959
Gross Margin	34.7	35.1	36.9	39.5	41.4	44.1	45.4	53.3	59.2	58.4	53.8	44.5	49.5	54.0	62.3
Total Operating Expenses	269	319	473	509	578	648	675	620	736	783	1,027	1,057	1,024	1,093	1,224
Operating Profit	49	53	98	105	138	131	114	114	172	118	119	-7	128	194	315
Operating Margin	15.4	14.2	17.2	17.1	19.3	16.8	14.5	15.5	18.9	13.1	10.4	-0.7	11.1	15.1	20.5
Financing Income/(Expense) - Net	2	2	-6	2	1	21	27	47	2	-8	-32	-43	-82	-51	-22
Profit before Taxes	53	57	95	108	142	153	144	144	188	197	106	-34	59	124	278
Income Taxes	12	10	20	35	36	42	34	26	33	49	42	-7	22	44	52
Profit after Tax	41	47	76	74	108	108	105	112	156	148	61	-32	32	78	243
PAT Margin	13.0	12.7	13.2	12.0	15.1	13.8	13.3	15.3	17.2	16.4	5.3	-3.1	2.8	6.1	15.8
EPS - Basic - ex Extraordinary Items	2.86	3.22	5.14	4.81	7.03	6.71	6.45	6.88	9.58	9.06	3.63	-1.87	1.84	4.02	12.44
EPS - Diluted - ex Extraordinary Items	2.86	3.22	4.91	4.81	6.95	6.71	6.45	6.88	9.58	9.06	3.63	-1.87	1.84	4.02	12.44
EBIT	49	53	98	105	138	131	114	114	172	118	119	-7	128	194	315
EBITDA	63	68	122	126	161	162	151	156	216	172	199	89	226	299	435
EBITDA Margin	19.9	18.3	21.3	20.6	22.5	20.7	19.2	21.3	23.8	19.1	17.4	8.4	19.6	23.2	28.2

Balance Sheet

Abridged

Understanding Balance Sheet

Shilpa Medicare Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	R 2012 Mar 31	C 2013 Mar 31	C 2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	R 2019 Mar 31	2020 Mar 31	R 2021 Mar 31	2022 Mar 31	R 2023 Mar 31	C 2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	188	212	234	344	358	730	672	545	621	903	887	770	876	986	1,110
Long-Term Investments	0	0	0	0	0	0	0	1	1	31	43	52	0	0	65
Property Plant & Equipment - Net	219	303	390	379	475	527	607	799	1,066	1,295	1,404	1,537	1,596	1,675	1,782
Total Non-Current Assets	245	339	444	471	668	742	827	1,065	1,365	1,730	1,988	2,134	2,217	2,325	2,596
Total Assets	433	551	678	815	1,026	1,472	1,499	1,610	1,986	2,632	2,875	2,904	3,093	3,311	3,706
Total Current Liabilities	121	124	167	198	223	237	266	253	408	604	612	784	694	674	848
Long Term Debt	5	70	67	16	2	143	68	81	167	476	355	291	561	233	185
Total Non-Current Liabilities	31	99	105	71	91	251	153	167	257	561	453	345	600	273	266
Total Liabilities	152	222	271	269	314	488	419	420	665	1,165	1,064	1,130	1,293	947	1,114
Total Shareholders' Equity	276	320	396	542	710	987	1,085	1,198	1,329	1,479	1,822	1,783	1,809	2,372	2,591
Minority Interest	5	9	10	4	2	-3	-5	-8	-8	-11	-11	-9	-9	-9	-
Total Equity	281	329	406	546	712	984	1,080	1,190	1,321	1,467	1,811	1,774	1,800	2,364	2,591
Total Liabilities & Equity	433	551	678	815	1,026	1,472	1,499	1,610	1,986	2,632	2,875	2,904	3,093	3,311	3,706

Cash Flow

Abridged

Understanding Cash Flow Statement

Shilpa Medicare Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	R 2013 Mar 31	R 2014 Mar 31	C 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	C 2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	61.53	58.49	93.37	108.82	130.67	129.91	115.65	118.94	187.89	133.94	138.76	20.51	143.60	201.68	330.40
Working Capital - Increase/(Decrease)	0.77	-13.90	-23.44	-40.11	-2.70	-92.61	-69.66	18.71	-63.80	-106.29	-71.99	102.77	-97.92	-138.18	-35.17
Net CF from Operating Activities	62.30	44.60	69.92	68.71	127.97	37.30	45.98	137.66	124.09	27.65	66.77	123.28	45.68	63.50	295.23
Capital Expenditures - Net	79.01	97.32	104.00	144.86	114.24	116.23	137.42	297.39	110.80	349.43	331.22	225.46	172.46	216.13	357.38
Net CF from Investing Activities	-159.70	-98.36	-52.36	-198.68	-112.41	-264.56	-12.35	-190.96	-293.47	-406.73	-288.51	-233.89	-167.97	-207.14	-326.57
Dividends Paid - Cash - Total	2.22	2.55	3.68	4.51	10.60	5.38	7.23	-	20.64	-	8.97	9.55	-	-	9.78
Stock - Issuance/(Retirement) - Net	13.13	3.62	-	81.45	-	172.21	-	-	-	-	296.84	-	-	489.10	-
Debt - LT & ST - Issuance/(Retirement) - Total	0.11	66.60	-21.32	58.56	-5.11	148.39	-51.48	2.97	193.46	458.24	-163.63	113.27	139.14	-349.72	71.00
Net Cash Flow from Financing Activities	11.84	68.50	-24.80	139.87	-15.71	315.21	-58.38	13.97	179.77	458.24	124.24	103.72	139.14	139.38	61.22
Free Cash Flow to Equity	-16.60	13.87	-55.39	-17.59	8.61	69.46	-142.92	-156.76	206.75	136.46	-428.08	11.09	12.37	-502.35	8.85
Free Operating CF net dividend	-19.07	-55.39	-37.87	-80.68	2.65	-85.20	-99.22	-162.32	-12.08	-326.59	-274.03	-112.93	-138.88	-180.13	-85.18
Free Operating CF	-16.84	-52.84	-34.18	-76.17	13.25	-79.82	-91.99	-162.32	8.56	-326.59	-265.06	-103.39	-138.88	-180.13	-75.40

Business Segment Analysis

FY End:

Mar 25

Shilpa Medicare Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Pharmaceutical products and services (100.0%)₹ 243.63 Cr

Revenue / Sales

Pharmaceutical products and services (100.0%)₹ 1,286.41 Cr

Assets

Pharmaceutical products and services (100.0%)₹ 3,310.71 Cr

Operating Income

Pharmaceutical products and services (100.0%)₹ 193.71 Cr

Regional Segment Analysis

FY End:

Mar 25

Shilpa Medicare Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (37.4%)₹ 480.48 CrEurope (23.4%)₹ 300.82 CrROW (21.0%)₹ 270.53 CrUnited States of America (18.2%)₹ 234.59 Cr

Historical Segment Analysis

Track how Shilpa Medicare Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Pharmaceutical products and services	116	354	332	273	185	244

Frequently Asked Questions

What is the revenue of Shilpa Medicare Ltd.?

The latest trailing twelve month revenue of Shilpa Medicare Ltd. is ₹ 3,077.74 Cr, reflecting a 1-year growth of 139.25% and a 3-year CAGR of 43.11%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Shilpa Medicare Ltd.?

The latest trailing twelve month net profit (PAT) of Shilpa Medicare Ltd. is ₹ 243.33 Cr. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Shilpa Medicare Ltd.?

The operating margin of Shilpa Medicare Ltd. is -. Detailed EBITDA history is available in the Income Statement section of the Statements tab.

What is the EPS of Shilpa Medicare Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Shilpa Medicare Ltd. is 12.44. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Shilpa Medicare Ltd.?

The debt-to-equity ratio of Shilpa Medicare Ltd. stands at 0.25. The interest coverage ratio is 5.65x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Shilpa Medicare Ltd.?

The estimated book value per share of Shilpa Medicare Ltd. is 134.27 (derived from a P/B ratio of 4.54 and market price of ₹ 608.95), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Shilpa Medicare Ltd.?

The trailing twelve month operating cash flow of Shilpa Medicare Ltd. is ₹ 295.23 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Shilpa Medicare Ltd. report consolidated or standalone financials?

Shilpa Medicare Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.